首頁 > 市場調查報告書 > 醫療設備

病患監測

市場調查報告書

商品編碼

1917981

睡眠監測設備市場－2026-2031年預測

Sleep Monitoring Devices Market - Forecast from 2026 to 2031

出版日期: 2026年01月12日 | 出版商:

Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計睡眠監測設備市場將從 2025 年的 261.56 億美元成長到 2031 年的 390.05 億美元，複合年成長率為 6.89%。

睡眠監測設備涵蓋了成熟的消費級穿戴裝置（腕帶、戒指、智慧型手錶）、近距離設備（床邊雷達、床墊下壓電感測器、智慧枕頭）以及臨床級多導睡眠圖（PSG）相關系統。關鍵測量指標正逐步標準化：活動記錄器、光電容積脈搏波描記法（PPG）（用於測量心率變異性）、血氧飽和度（SpO2）、呼吸努力程度、體溫，以及透過乾電極頭帶或耳內感測器取得的腦電圖（EEG）睡眠分期。

穿戴式裝置佔總銷量的 85% 以上，約佔總收入的 70%。 Oura Ring Gen 3、Whoop 4.0、Fitbit Sense 2/Charge 6、Apple Watch Series 9/Ultra 2、Samsung Galaxy Watch 7 和 Garmin Vivosmart/Venu 系列目前均提供檢驗的睡眠分期準確度，與多導睡眠圖 (PSG) 測量結果相比，淺睡眠、深睡眠和快速眼動圖 (REM12 ±12%持續的血氧飽和度 (SpO2) 和呼吸頻率監測已成為必備功能，從而可以對人群阻塞型睡眠呼吸中止症中止症 (ESA)篩檢。據估計，ESA 在成人中的盛行率為 15-30%，而未確診率超過 80%。

成長要素在於人們對睡眠障礙的認知不斷提高以及報銷途徑的不斷拓展。在美國，醫療保險和醫療補助服務中心 (CMS) 於 2024 年新增了對某些獲得 FDA 批准的穿戴式睡眠診斷設備的有限報銷，而私人保險公司（如 UnitedHealthcare 和 Aetna）現在已將基於 watchPAT 的家庭睡眠呼吸中止症檢測作為一級證據。同樣，歐洲的 DiGA 加速核准系統和英國NHS 數位健康技術路徑也使得檢驗的數位睡眠藥物（如 Somryst 和 Sleepio）及其配套診斷產品能夠獲得報銷。

臨床應用在循環系統和神經病學領域最為迅速。夜間連續心率變異性 (HRV) 和血氧飽和度 (SpO2) 數據正被整合到遠端患者監護(RPM) 工作流程中，用於心臟衰竭和中風後患者的監測（CPT 代碼 99457/99458）。癲癇中心正在使用多模態穿戴裝置進行與癲癇發作相關的睡眠片段化分析。居家醫院計畫也擴大採用獲得 FDA 批准的近穿戴式裝置（例如 Withings Sleep Analyzer 和 ResMed NightOwl），以降低病患的再入院風險。

市場分為兩個消費者群體：

高階產品（300-550美元）－Oura、Whoop、Ultrahuman Ring Air、Eight Sleep Pod。這些產品著重於恢復評分、基於心率變異性（HRV）的訓練負荷以及與溫度調節床墊的整合。
福斯市價位（80-250美元）－小米手環9、Amazfit、Fitbit。這些型號主打14-21天的續航時間，並提供基本的睡眠階段和血氧飽和度追蹤功能。

人們對睡眠監測設備的準確性期望值正在急劇上升。包括史丹佛大學、哈佛大學和魯汶大學在內的獨立檢驗研究，經常將消費級設備與多導睡眠圖（PSG）進行比較，頂級設備在四個睡眠階段（清醒/淺睡眠/深睡眠/快速眼動睡眠）的準確率均達到82-88%（相比之下，醫用活動記錄儀的準確率超過90%）。製造商則透過混合機器學習模型（這些模型基於數百萬個夜晚的睡眠資料進行訓練）和持續的韌體更新來應對這項挑戰。

隱私和資料所有權正在成為新的差異化因素：本地設備內處理（Apple S9/SiP、Google Tensor）無需雲端上傳即可進行睡眠分期，而免訂閱模式（Garmin、Withings）正在從 Whoop 和 Oura 的定期收費結構中重新奪回市場佔有率。

總之，睡眠監測設備市場已跨越臨界點，從健康小工具轉型為臨床實用工具。成功越來越依賴以下三個方面：(1) 透過多導睡眠圖 (PSG)檢驗，準確檢測睡眠呼吸中止症和晝夜節律生物標記；(2) 無縫整合到遠端病患管理 (RPM) 和慢性病管理工作流程中，並提供可報銷的資料輸出；(3) 在支付方和雇主對生物辨識資料建置權限不斷擴大的時代，可靠的隱私保護；(3) 在支付方和雇主對生物辨識資料建置權限不斷擴大的時代，可靠的隱私保護架構。隨著睡眠從生活方式指標轉變為標準生命徵象，那些將醫療級感測器融合技術與符合人體工學的消費者友好型設計以及清晰的監管和報銷途徑相結合的公司，將獲得最大的市場價值。

本報告的主要優勢：

深入分析：取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察，涵蓋主要地區和新興地區。
競爭格局：了解主要企業採取的策略舉措，並了解透過正確的策略打入市場的潛力。
市場促進因素與未來趨勢：探索動態因素和關鍵市場趨勢，以及它們將如何塑造未來的市場發展。
可執行的建議：利用洞察力為策略決策提供訊息，從而在動態環境中開拓新的業務管道和收入來源。
受眾範圍廣：對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及其影響、新產品開發、競爭影響

分析範圍

歷史資料（2021-2025 年）和預測資料（2026-2031 年）
成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
競爭對手定位、策略和市場佔有率分析
按業務板塊和地區（國家）分類的收入成長和預測分析
公司概況（策略、產品、財務資訊、關鍵趨勢等）

Sleep monitoring devices encompass a maturing ecosystem of consumer wearables (wristbands, rings, smartwatches), nearables (bedside radar, under-mattress piezo sensors, smart pillows), and clinical-grade PSG-adjacent systems. Core metrics have standardized around actigraphy, photoplethysmography (PPG) heart-rate variability, SpO2, respiratory effort, body temperature, and, increasingly, EEG-derived sleep staging via dry-electrode headbands or in-ear sensors.

Wearables dominate >85 % of unit volume and ≈70 % of revenue. Oura Ring Gen 3, Whoop 4.0, Fitbit Sense 2/Charge 6, Apple Watch Series 9/Ultra 2, Samsung Galaxy Watch 7, and Garmin Vivosmart/Venu lines now deliver validated sleep-staging accuracy within +-10-12 % of PSG for light/deep/REM classification. Continuous SpO2 and respiratory-rate tracking have become table stakes, enabling population-level screening for undiagnosed obstructive sleep apnea (estimated prevalence 15-30 % in adults, >80 % undiagnosed).

The primary growth driver remains the convergence of rising sleep-disorder awareness with expanding reimbursement pathways. In the U.S., CMS added limited coverage for certain FDA-cleared wearable-derived sleep diagnostics in 2024, while private payors (UnitedHealthcare, Aetna) now recognize watchPAT-style home sleep apnea testing as Tier 1 evidence. Europe's DiGA fast-track and NHS Digital Health Technology pathways have similarly opened reimbursement for validated digital sleep therapeutics (Somryst, Sleepio) and companion diagnostics.

Clinical adoption is accelerating fastest in cardiology and neurology. Continuous nocturnal HRV and SpO2 data are now integrated into remote patient monitoring (RPM) CPT 99457/99458 workflows for heart-failure and post-stroke patients, while epilepsy centers use multimodal wearables for seizure-related sleep fragmentation analysis. Hospital-at-home programs increasingly deploy FDA-cleared nearables (Withings Sleep Analyzer, ResMed NightOwl) to reduce readmission risk.

Consumer segmentation has bifurcated:

Premium tier ($300-550) - Oura, Whoop, Ultrahuman Ring Air, Eight Sleep Pod, focusing on recovery scores, HRV-guided training load, and temperature-regulated bedding integration.
Mass tier ($80-250) - Xiaomi Mi Band 9, Amazfit, Fitbit, emphasizing 14-21 day battery life and basic sleep-stage + SpO2 tracking.

Accuracy expectations have risen sharply. Independent validation studies (e.g., Stanford, Harvard, KU Leuven) now routinely benchmark consumer devices against PSG, with top performers achieving 82-88 % four-stage (wake/light/deep/REM) Cohen's kappa versus 90 %+ for medical actigraphy. Manufacturers have responded with hybrid machine-learning models trained on multi-million-night datasets and continuous firmware updates.

Privacy and data ownership are emerging differentiators. Local-on-device processing (Apple S9/SiP, Google Tensor) now enables sleep staging without cloud upload, while subscription-free models (Garmin, Withings) are regaining share against Whoop and Oura's recurring-fee structures.

In conclusion, the sleep monitoring device market has crossed the inflection point from wellness gadget to clinically actionable tool. Success increasingly hinges on three capabilities: (1) validated accuracy against PSG for sleep apnea and circadian biomarkers, (2) seamless integration into RPM and chronic-disease management workflows with reimbursable data outputs, and (3) defensible privacy architecture in an era of expanding payer and employer access to biometric data. Companies that combine medical-grade sensor fusion with consumer-grade ergonomics and clear regulatory/reimbursement pathways will capture the lion's share of value as sleep moves from lifestyle metric to standard-of-care vital sign.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2021 to 2025 & forecast data from 2026 to 2031
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Sleep Monitoring Devices Market Segmentation:

By Product Type
Wearable
Watches And Wrist Bands
Rings
Earbuds
Others
Non-Wearable
Bed Sensors
Bed Side Devices
By Distribution Channel
Online
Offline
By Geography
North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. SLEEP MONITORING DEVICES MARKET BY PRODUCT TYPE

5.1. Introduction
5.2. Wearable
- 5.2.1. Watched And Wrist Bands
- 5.2.2. Rings
- 5.2.3. Earbuds
- 5.2.4. Others
5.3. Non-Wearable
- 5.3.1. Bed Sensors
- 5.3.2. Bed Side Devices

6. SLEEP MONITORING DEVICES MARKET BY DISTRIBUTION CHANNEL

6.1. Introduction
6.2. Online
6.3. Offline

7. SLEEP MONITORING DEVICES MARKET BY GEOGRAPHY

7.1. Introduction
7.2. North America
- 7.2.1. USA
- 7.2.2. Canada
- 7.2.3. Mexico
7.3. South America
- 7.3.1. Brazil
- 7.3.2. Argentina
- 7.3.3. Others
7.4. Europe
- 7.4.1. Germany
- 7.4.2. France
- 7.4.3. United Kingdom
- 7.4.4. Spain
- 7.4.5. Others
7.5. Middle East and Africa
- 7.5.1. Saudi Arabia
- 7.5.2. UAE
- 7.5.3. Others
7.6. Asia Pacific
- 7.6.1. China
- 7.6.2. India
- 7.6.3. Japan
- 7.6.4. South Korea
- 7.6.5. Indonesia
- 7.6.6. Thailand
- 7.6.7. Others